Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Y3R5: Medicine I 🩺 > L9: Thyrotoxicosis > Flashcards

L9: Thyrotoxicosis Flashcards

1
Q

Anatomy of Thyroid Gland

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Histology of Thyroid Gland

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Synthesis of thyroid Hormones

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Forms of thyroid hormone

A

Thyroid hormones circulate in 2 forms:

  • Protein bound, mainly thyroxin binding globulin ( TBG ): > 99%
  • Free part ( active part ) : less than 1 %
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hypothalamic-Pituitary-Thyroid Axis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Actions of Thyroid Hormones

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Def of Thyrotoxicosis

A

A clinical state that results from any condition leading to high thyroid hormone action in tissues. Irrespective of the source.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Def of Hyperthyroidism

A

Form of thyrotoxicosis caused by high synthesis and
secretion of thyroid hormone by the thyroid gland.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Characters of Subclinical
hyperthyroidism/thyrotoxicosis

A
  • Biochemically as the presence of low thyroid-
    stimulating hormone (TSH) and normal free thyroxine
    (FT4) and free triiodothyronine (FT3) concentrations.
  • Patients can be asymptomatic or symptoms of thyrotoxicosis may be present.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Characters of Overt primary
thyrotoxicosis

A
  • Refers to suppressed TSH with high levels of FT4, FT3, or both.
  • Patients can be asymptomatic or more commonly present with symptoms of hyperthyroidism.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Def of Thyrotoxic crisis
(thyroid storm)

A
  • a life-threatening, acute, and rapid collapse of homeostasis, developing as a result of undiagnosed or inadequately treated thyrotoxicosis and involving altered mental status that may progress to coma, cardiac and multiorgan failure, shock, and death.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Etiology of Thyrotoxicosis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Def of Grave’s Disease

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The most common causes of Thyrotoxicosis

A

raves’ disease, followed by  toxic multinodular goiter and toxic adenoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Incidence of Grave’s Disease

A
  • it is the most common cause of hyperthyroidism & occurs at all ages but especially in women of reproductive age
  • Peak incidence 20-40 years.
  • Female to male incidence 5-8 :1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pathogenesis of Grave’s Disease

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Abs in Grave’s Disease

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Immune Mechanisms in Grave’s Disease

A

Include:

  • molecular mimicry and thyroid-cell expression of human leukocyte antigen (HLA) class II molecules (notably HLA-DR).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Who is suseptible to Grave’s Disease?

A

Female sex and genetic susceptibility

(cluster in families)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are possible ppt factors for Grave’s Disease?

A

 Infection
 Stress- Smoking
 Pregnancy
 Iodine and iodine-containing drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mechanism of autoimmunity in Grave’s Disease

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The pathophysiology of GO & pretibial myxedema involves

A

involves the synergism of insulin-like growth factor 1 receptor (IGF1R) with TSHR autoantibodies, causing retro orbital tissue expansion and inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

CP of Subclinical Thyrotoxicosis/Hyperthyroidism

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

CP of Long-Standing Subclinical Thyrotoxicosis/Hyperthyroidism

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Aspects of CP of Overt thyrotoxicosis

A

Refer to summary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

General Symptoms

  • CP of TTx
A

Refer to notes …

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Neuropsychiatryic Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

MSK Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

CVS Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Resp Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

GIT Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Reproductive Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Renal Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Dermatologic Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Eye Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Metabolic Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Bone Symptoms

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Neck Abnormalities

  • CP of TTx
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Autommune Diseases associated with GD

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Lab Dx of Graves Disease

A
  • Thyroid Function Tests
  • Thyroid-stimulating antibody (TSab)
  • Other lab tests
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Thyroid Function Tests in Graves Disease

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

T3 Toxicosis

A

T3 level only may be ↑ in some cases (T3 toxicosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Subclinical hyperthyroidism

A

low serum TSH concentrations (<0.4 mU/L) but normal serum free T4, and T3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

TSAB in Graves Disease

A
  • Also known as thyroid-stimulating immunoglobulin (TSI), or TSH-receptor antibody (TRAb)
  • Positive test is diagnostic and specific for Graves’ disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Significance of TGB

A

Serum thyroglobulin TG levels are useful only for excluding thyrotoxicosis caused by exogenous thyroid hormone excess, in which case serum TG is low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Other Lab tests of Graves Disease

A
47
Q

Rad investigations for Graves Disease

A
  • RAIU
  • Thyroid scan (scintigraphy)
  • Ultrasonography
  • Orbital CT or magnetic resonance imaging (MRI)
  • Neck CT
48
Q

RAIU in Graves Disease

A

Measures the percentage of function of the thyroid gland.

  • A high (typical of GD or toxic nodule or nodules)
  • A low uptake suggests inflammation or destruction of the thyroid gland (such as in thyroiditis)
49
Q

Thyroid Scan in Graves Disease

A
50
Q

US in Graves Disease

A
  • of the thyroid gland with assessment of thyroid blood flow also useful to characterize palpable nodules
  • Normoechogenic and diffuse large glands, may be enlarged LNs.
  • Color flow Doppler shows high blood flow
51
Q

Orbital CT or magnetic resonance imaging (MRI)

  • Graves Disease
A
  • In patients with Graves’ orbitopathy —> an increased volume of extraocular muscles and/or retro bulbar connective tissue
52
Q

Neck CT in Graves Disease

A

only for selected suspicious cases.

53
Q

Cytology in Graves Disease

A

Used to classify thyroid nodules as malignant (thyroid cancer), suspicious, or nonmalignant in order to determine indications for surgery.

54
Q

DDx of Graves Disease

A
55
Q

TTT of Graves Disease

A

A. Medical ( Antithyroid drugs and others )
B. Thyroidectomy
C. Radiotherapy
D. Management of thyrotoxicosis in pregnancy
E. Treatment of complications

56
Q

Members of Anti-thyroid Drugs

A

Methimazole, carbimazole and propylthiouracil (PTU)

57
Q

MOA of Anti-thyroid Drugs

A

 These drugs inhibit the formation of thyroid hormones.

 Propylthiouracil also inhibits conversion of T4 to T3

58
Q

Drug of Choice in GD

A

Methimazole

59
Q

Dose of Methimazole in GD

A

⇒ The dose depends on the severity of thyrotoxicosis and varies between 2.5 and 40 mg/day orally.

⇒ Thyroid function tests should be monitored closely and Methimazole tapered to a maintenance dose aiming to achieve euthyroidism.

⇒ In severe hyperthyroidism use up to 60 mg/d orally in 2 to 3 divided doses, and in impending Thyrotoxic crisis, up to 120 mg/d orally or IV (in hospitalized patients).

60
Q

Monitoring of Methimazole

A

Thyroid function tests should be monitored closely and Methimazole tapered to a maintenance dose aiming to achieve euthyroidism.

61
Q

DOC in GD in pregnancy

A

propylthiouracil (PTU) is used (in the first trimester)

62
Q

Check up in GD

A
63
Q

Indications of Anti-Thyroid Drugs

A

1) Mild disease and small goiter because they have high chance of remission

2) Elderly or other comorbidities increasing surgical risk.

3) Limited life expectancy

4) Previous operation or irradiation to the neck

64
Q

CI of Anti-Thyroid Drugs

A
  • Huge and retro-sternal goiter.
  • Suspicion of malignancy.
65
Q

SE of Anti-Thyroid Drugs

A
66
Q

what are adjuvant medical therapy in GD?

A

B-Blockers

67
Q

Indicatins of adjuvant medical therapy in GD

A
  • All thyroid patients with resting heart rate >90/min.
  • Elderly patients with symptomatic thyrotoxicosis.
68
Q

Classes of adjuvant medical therapy in GD

A
  • Non selective (propranolol in divided doses) Controls both cardiac and psychomotor manifestations.
  • Selective B blockers: atenolol 25 to 50 mg daily, once : Control cardiac arrhythmias resulting from hyperthyroidism
69
Q

what are Other adjuvant medical therapy in GD?

A
  • iodine, glucocorticoid, cholestyramine, lithium, and Rituximab.
70
Q

uses of other adjuvant medical therapy in GD

A

May benefit in patients with severe hyperthyroidism or who are allergic to thionamides.

71
Q

Surgery of Choice in GD

A

Near-total or total thyroidectomy is the procedure of choice

72
Q

Indications of Surgery in GD

A

 Failure of response to anti-thyroid drugs.
 Severe adverse reactions to anti-thyroid drugs.
 Patient refuses radioactive iodine treatment.
 Huge goiter which cause pressure symptoms.
 Suspected malignancy in thyroid gland.

73
Q

POC for Surgery in GD

A

 Anti-thyroid drugs to reduce hyperfunction.

 β-blockers to control pulse rate below 80/min.

 Potassium iodide may be given for 2 weeks before surgery. It reduce intraoperative blood loss.

74
Q

Complications of Surgery in GD

A
  1. Early bleeding, hematoma.
  2. Laryngeal nerve palsy occurs in 1%.
  3. Transient hypocalcaemia occurs in up to 10% but with Permanent hypoparathyroidism in less than 1%.
  4. Recurrent hyperthyroidism
  5. Hypothyroidism occurs in about 10% of patients within 1 year, and this percentage increases with time.
  6. Complications of general anesthesia.
75
Q

Characters of RAI in GD

A

⇒ Suitable for most patients with Graves’ disease.

⇒ It is effective, safe, and does not require hospitalization.

⇒ Given orally in a single dose in a capsule or liquid form.

⇒ Very few side effects as no other tissue absorb RAI.

76
Q

Precautions before RAI in GD

A

Patients with severe hyperthyroidism, elderly patients or patients with underlying heart disease should be pretreated with anti-thyroid drugs and β- blockers to achieve a euthyroid state prior to radio-active iodine.

77
Q

Indications of RAI in GD

A
  1. ↑ Surgical risk due to associated comorbidities.
  2. Previous operation or irradiation to the neck.
  3. Contraindication for use of anti-thyroid drugs.
  4. Recurrence after surgery.
78
Q

Disadvantages of RAI in GD

A
  1. Permanent hypothyroidism
  2. Rarely radiation thyroiditis
  3. Worsening or development of Graves opthalmopathy
  4. Patient must take radiation precautions for several days after treatment, avoiding contact with young children and pregnant women.
79
Q

CI of RAI in GD

A

 Pregnancy and lactation.
 Children
 Associated severe opthalmopathy

80
Q

Radioactive TTT of TTx during Preganncy

A

Absolutely contraindicated (teratogenic)

80
Q

TTT of HF

Complications of GD

A

bed rest, salt restriction, digitalis & diuretics.

80
Q

Medical TTT of TTx during Preganncy

A
81
Q

Surgery in TTx during Preganncy

A
  • Indicated in women who cannot tolerate side effects of anti-thyroid drugs.
  • Surgery can be performed (preferably in the second trimester).
82
Q

TTT of Dermopathy

Complications of GD

A
  • Milder cases do not require ttt, for other cases therapy with topical steroids applied under an occlusive plastic dressing film for 3-10 weeks
    has been helpful.
83
Q

TTT of Bone Disease due to hyperthyroidism

Complications of GD

A
  • Treat hyperthyroidism, give adequate amounts of calcium and vitamin D in diets, typically 1000 to 1200 mg of calcium (total of diet and supplement) and 600 to 800 international units of vitamin D., Only those with highest risk for fracture could benefit from
    bisphosphonate therapy
84
Q

what is thyrotoxic Crisis?

A
  • Thyrotoxic crisis is an acute life-threatening exacerbation of thyrotoxicosis in patients who have undiagnosed or inadequately treated thyrotoxicosis and superimposed precipitant factors
  • A rare, life-threatening, hypermetabolic condition of severe clinical manifestations of thyrotoxicosis.
85
Q

Physiology of thyrotoxic Crisis

A

Caused by excessive release of thyroid hormones

86
Q

what percipitates thyrotoxic Crisis?

A
87
Q

CP of thyrotoxic Crisis

A
88
Q

TTT of thyrotoxic Crisis

A

Start treatment immediately, without waiting for confirmation by laboratory tests.
Continue treatment at an intensive care unit.

  • Drugs
  • Symptomatic
  • TTT of Cause
89
Q

Drugs in TTT of thyrotoxic Crisis

A
90
Q

Symptomatic TTT of thyrotoxic Crisis

A

 Antipyretics : ice bags and acetaminophen

IV fluids for dehydration

 Digoxin and diuretics for AF& HF

 Nasogastric tube for bulbar palsy, nausea and vomiting

91
Q

TTT of Cause of thyrotoxic Crisis

A

antibiotics for infection

92
Q

what are other names of Thyroid eye disease (TED)?

A

Graves’s opthalmopathy or Graves’s
orbitopathy

93
Q

Incidence of Thyroid eye disease (TED)

A
  • It is the most common cause of unilateral and bilateral proptosis in adults.
  • About 25 to 50% of Grave disease (GD) cases present with thyroid eye disease.
94
Q

Pathology of Thyroid eye disease (TED)

A
  • A chronic immunemediated inflammation of the orbit.
  • There is an orbital inflammation or infiltration involving the soft tissues, proptosis, and ophthalmoplegia.
95
Q

Etiology of Thyroid eye disease (TED)

A
96
Q

Pathophysiology of Thyroid eye disease (TED)

A
97
Q

CP of Thyroid eye disease (TED)

A
98
Q

Symptoms of Thyroid eye disease (TED)

A
  • The patient complains of gritty sensations, photophobia, lacrimation, dry eye, discomfort, and forward protrusion of the eye.
  • In more advanced cases, patient may complain eye socket (orbital) pain, double vision, or blurred vision
99
Q

Eye Signs of Thyroid eye disease (TED)

A
100
Q

Dx of Thyroid eye disease (TED)

A
  • Exophthalmometer
  • Imaging
101
Q

Exophthalmometer

Dx of Thyroid eye disease (TED)

A

Assess the degree of proptosis by
- Measurement of the distance between the lateral angle of the bony orbit and an imaginary line tangent to the most anterior part of the cornea.

  • The upper limit of normal is 21 mm in males and 19 mm in females.
102
Q

Imaging

Dx of Thyroid eye disease (TED)

A
103
Q

Managment of Thyroid eye disease (TED)

A
104
Q

Etiology of Toxic MNG

A
  • It occurs more commonly in elderly individuals, especially those with a long-standing goiter.
  • Caused by hyperplasia of thyroid follicular cells due to activating somatic mutations of the TSH receptor genes.
105
Q

CP of Toxic MNG

A

 Nodular thyroid enlargement.
 Manifestations of thyrotoxicosis.
 No opthalmopathy or dermopathy.

106
Q

Thyroid Scan in Toxic MNG

A

 Multiple areas of hyperactivity (hot areas)
 Interspersed with hypoactive regions.

107
Q

TTT of Toxic MNG

A
  • Surgery or radioiodine can be used.
  • If surgery is chosen, near-total or total thyroidectomy should be performed.
108
Q

Etiology of Toxic adenoma

A
  • Caused by a single hyper functioning follicular thyroid adenoma due to mutation in TSH receptor gene.
109
Q

CP of Toxic adenoma

A

 Solitary thyroid nodule.
 Manifestations of thyrotoxicosis.
 No opthalmopathy or dermopathy

110
Q

Thyroid scan of Toxic adenoma

A
  • Hyperactive (hot) area,
  • the rest of the gland may be hypoactive.
111
Q

TTT of Toxic adenoma

A
  • Surgery or radioiodine can be used.
  • If surgery is chosen, an ipsilateral thyroid lobectomy or isthmusectomy should be performed
112
Q

Done

A

..

Y3R5: Medicine I 🩺 (47 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions